Hydrogels for therapeutic cardiovascular angiogenesis

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Acute myocardial infarction (MI) leads to cardiac dysfunction due to ischemia.
• Limited retention of growth factors or cells in the myocardium hinders sustained therapeutic responses.
• Effective delivery systems are needed to enhance localized delivery of therapeutic agents for ischemic tissues.

Purpose of the Study:

• To review hydrogel systems for localized delivery of growth factors and/or cells.
• To highlight the application of hydrogels in promoting therapeutic angiogenesis in ischemic tissues, particularly the myocardium.
• To discuss the advantages of hydrogels as pro-angiogenic matrices.

Main Methods:

• Review of existing literature on hydrogel-based therapeutic angiogenesis.
• Analysis of hydrogel properties (ECM similarity, mild processing, minimally invasive delivery, tunable degradation).
• Focus on hydrogel applications in myocardial infarction and ischemic tissue repair.

Main Results:

• Hydrogels mimic the extracellular matrix (ECM), facilitating better integration and retention of bioactive agents.
• Hydrogels can be designed for controlled degradation, aligning with the angiogenic process.
• Various hydrogel systems show potential for enhancing localized delivery of growth factors and cells for therapeutic angiogenesis.

Conclusions:

• Hydrogels are advantageous carrier systems for localized delivery of therapeutics in ischemic conditions.
• Their properties make them suitable for promoting therapeutic angiogenesis in myocardial applications.
• Hydrogels represent a promising strategy for improving outcomes in acute myocardial infarction and other ischemic diseases.